Search results
Researchers discover new target for potential leukemia therapy
Medical Xpress· 6 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
Earnings call: Moleculin Biotech optimistic on Annamycin's future By Investing.com
Investing.com· 1 day agoThe company has secured a composition of matter patent for Annamycin, ensuring market exclusivity...
Earnings call: Moleculin Biotech optimistic on Annamycin's future By Investing.com
Investing.com· 1 day agoThe company has secured a composition of matter patent for Annamycin, ensuring market exclusivity...
Curis Announces Additional Data from TakeAim Leukemia Study
WRBL Columbus· 5 hours agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced updated data from ...
Sutro Biopharma shares hold on luvelta prospects By Investing.com
Investing.com· 11 hours agoAdditionally, Sutro Biopharma plans to initiate the REFRaME-P1 pediatric study in the second half of...
Obituary - Steven Michael Kakuska
Fontana Herald News· 4 days agoSteven Michael Kakuska’s battle with acute myeloid leukemia ended on Saturday, March 27, when he passed away at Kaiser Hospital in Fontana ...
Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Show
MedPage Today· 6 days agoVenetoclax (Venclexta) combined with a hypomethylating agent (HMA) -- the standard of care for older...
Jury Says Exxon Mobil Must Pay $725 Million to Former Mechanic Who Developed Cancer
The Wall Street Journal· 4 days agoA Pennsylvania jury found Exxon Mobil liable for about $725 million in compensatory damages to a...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 hours ago– Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and TP53m AML patients; successfully bridged responding TP53m AML patients to hematopoietic cell transplantation – – SL
Philadelphia jury awards former mechanic $725.5M in Exxon Mobil case
Philly.com· 4 days agoA Philadelphia jury sided against Exxon Mobil Corp. and awarded $725.5 million on Thursday to a...